Blastocystis: how do specific diets and human gut microbiota affect its development and pathogenicity?

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 36, Issue 9, 2017, Pages 1531-1540

  Lepczynska M ^a   Bialkowska J ^a   Dzika, E ^a   Piskorz Ogorek K ^a,b   Korycinska J ^a  

^a UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

^b Regional Children's Specialized Hospital   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ORGANIC COMPOUND; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; BLASTOCYSTIS; BLASTOCYSTOSIS; CLASSIFICATION; COMPARATIVE EFFECTIVENESS; DIET; DIET THERAPY; DRUG EFFICACY; ERADICATION THERAPY; GARLIC; GENETIC VARIABILITY; GINGER; HUMAN; INTESTINE; INTESTINE FLORA; KNOWLEDGE; LIFE CYCLE; MEDICINAL PLANT; MICROBIAL GENETICS; MICROBIAL GROWTH; MOLECULAR EPIDEMIOLOGY; MOLECULAR PATHOLOGY; NONHUMAN; PARASITE CLEARANCE; PARASITE DEVELOPMENT; PARASITE VIRULENCE; PRIORITY JOURNAL; REVIEW; SPECIES COMPOSITION; SPICE; DRUG EFFECT; GASTROINTESTINAL TRACT; GENETIC VARIATION; IMMUNOLOGY; LIFE CYCLE STAGE; MICROBIOLOGY; PARASITOLOGY; PATHOGENICITY; PHYSIOLOGY;

ANTI-BACTERIAL AGENTS; BLASTOCYSTIS; BLASTOCYSTIS INFECTIONS; DIET; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; GENETIC VARIATION; HUMANS; LIFE CYCLE STAGES;

EID: 85015729744     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-017-2965-0     Document Type: Review

References (148)

1. Tan KS (2008) New insights on classification, identification, and clinical relevance of Blastocystis spp. Clin Microbiol Rev 21:639–665. doi:10.1128/CMR.00022-08
2. Moosavi A, Haghighi A, Mojarad EN, Zayeri F, Alebouyeh M, Khazan H, Kazemi B, Zali MR (2012) Genetic variability of Blastocystis sp. isolated from symptomatic and asymptomatic individuals in Iran. Parasitol Res 111:2311–2315. doi:10.1007/s00436-012-3085-5
3. Basak S, Rajurkar MN, Mallick SK (2014) Detection of Blastocystis hominis: a controversial human pathogen. Parasitol Res 113:261–265. doi:10.1007/s00436-013-3652-4
4. Wawrzyniak I, Poirier P, Viscogliosi E, Dionigia M, Texier C, Delbac F, Alaoui HE (2013) Blastocystis, an unrecognized parasite: an overview of pathogenesis and diagnosis. Ther Adv Infect Dis 1:167–178. doi:10.1177/2049936113504754
5. Lukeš J, Stensvold CR, Jirků-Pomajbíková K, Wegener Parfrey L (2015) Are human intestinal eukaryotes beneficial or commensals? PLoS Pathog 11(8), e1005039. doi:10.1371/journal.ppat.1005039
6. Silberman JD, Sogin ML, Leipe DD, Clark CG (1996) Human parasite finds taxonomic home. Nature 380:398. doi:10.1038/380398a0
7. Irikov OA, Antokhin AI, Romanov YA (2009) Study of the dynamics of Blastocystis hominis reproduction in vitro. Bull Exp Biol Med 148:99–102. doi:10.1007/s10517-009-0651-7
8. Stensvold CR, Suresh GK, Tan KS, Thompson RC, Traub RJ, Viscogliosi E, Yoshikawa H, Clark CG (2007) Terminology for Blastocystis subtypes—a consensus. Trends Parasitol 23:93–96. doi:10.1016/j.pt.2007.01.004
9. Parija SC, Jeremiah S (2013) Blastocystis: taxonomy, biology and virulence. Trop Parasitol 3:17–25. doi:10.4103/2229-5070.113894
10. Alfellani MA, Taner-Mulla D, Jacob AS, Imeede CA, Yoshikawa H, Stensvold CR, Clark CG (2013) Genetic diversity of Blastocystis in livestock and zoo animals. Protist 164:497–509. doi:10.1016/j.protis.2013.05.003
11. Forsell J, Granlund M, Stensvold CR, Clark CG, Evengård B (2012) Subtype analysis of Blastocystis isolates in Swedish patients. Eur J Clin Microbiol Infect Dis 31:1689–1696. doi:10.1007/s10096-011-1416-6
12. Souppart L, Sanciu G, Cian A, Wawrzyniak I, Delbac F, Capron M, Dei-Cas E, Boorom K, Delhaes L, Viscogliosi E (2009) Molecular epidemiology of human Blastocystis isolates in France. Parasitol Res 105:413–421. doi:10.1007/s00436-009-1398-9
13. Noël C, Dufernez F, Gerbod D, Edgcomb VP, Delgado-Viscogliosi P, Ho LC, Singh M, Wintjens R, Sogin ML, Capron M, Pierce R, Zenner L, Viscogliosi E (2005) Molecular phylogenies of Blastocystis isolates from different hosts: implications for genetic diversity, identification of species, and zoonosis. J Clin Microbiol 43:348–355. doi:10.1128/JCM.43.1.348-355.2005
14. Yoshikawa H, Wu Z, Pandey K, Pandey BD, Sherchand JB, Yanagi T, Kanbara H (2009) Molecular characterization of Blastocystis isolates from children and rhesus monkeys in Kathmandu, Nepal. Vet Parasitol 160:295–300. doi:10.1016/j.vetpar.2008.11.029
15. Abe N (2004) Molecular and phylogenetic analysis of Blastocystis isolates from various hosts. Vet Parasitol 120:235–242. doi:10.1016/j.vetpar.2004.01.003
16. Rivera WL (2008) Phylogenetic analysis of Blastocystis isolates from animal and human hosts in the Philippines. Vet Parasitol 156:178–182. doi:10.1016/j.vetpar.2008.06.001
17. Roberts T, Stark D, Harkness J, Ellis J (2014) Update on the pathogenic potential and treatment options for Blastocystis sp. Gut Pathog 6:17. doi:10.1186/1757-4749-6-17
18. Yakoob J, Jafri W, Beg MA, Abbas Z, Naz S, Islam M, Khan R (2010) Irritable bowel syndrome: is it associated with genotypes of Blastocystis hominis. Parasitol Res 106:1033–1038. doi:10.1007/s00436-010-1761-x
19. Bálint A, Dóczi I, Bereczki L, Gyulai R, Szűcs M, Farkas K, Urbán E, Nagy F, Szepes Z, Wittmann T, Molnár T (2014) Do not forget the stool examination!—cutaneous and gastrointestinal manifestations of Blastocystis sp. infection. Parasitol Res 113:1585–1590. doi:10.1007/s00436-014-3805-0
20. Tan KSW, Mirza H, Teo JDW, Wu B, Macary PA (2010) Current views on the clinical relevance of Blastocystis spp. Curr Infect Dis Rep 12:28–35. doi:10.1007/s11908-009-0073-8
21. Scanlan PD, Stensvold CR, Rajilić-Stojanović M, Heilig HG, De Vos WM, O’Toole PW, Cotter PD (2014) The microbial eukaryote Blastocystis is a prevalent and diverse member of the healthy human gut microbiota. FEMS Microbiol Ecol 90:326–330. doi:10.1111/1574-6941.12396
22. Alfellani MA, Stensvold CR, Vidal-Lapiedra A, Onuoha ES, Fagbenro-Beyioku AF, Clark CG (2013) Variable geographic distribution of Blastocystis subtypes and its potential implications. Acta Trop 16:11–18. doi:10.1016/j.actatropica.2012.12.011
23. Stensvold CR (2013) Blastocystis: genetic diversity and molecular methods for diagnosis and epidemiology. Trop Parasitol 3:26–34. doi:10.4103/2229-5070.113896
24. Li LH, Zhou XN, Du ZW, Wang XZ, Wang LB, Jiang JY, Yoshikawa H, Steinmann P, Utzinger J, Wu Z, Chen JX, Chen SH, Zhang L (2007) Molecular epidemiology of human Blastocystis in a village in Yunnan province, China. Parasitol Int 56:281–286. doi:10.1016/j.parint.2007.06.001
25. Chen TL, Chan CC, Chen HP, Fung CP, Lin CP, Chan WL, Liu CY (2003) Clinical characteristics and endoscopic findings associated with Blastocystis hominis in healthy adults. Am J Trop Med Hyg 69:213–216
26. Raś-Noryńska M, Białkowska J, Sokół R, Piskorz-Ogórek K (2011) Parasitological stool examination from children without the typical symptoms of parasitic disease. Przegl Epidemiol 65:599–603
27. Kaneda Y, Horiki N, Cheng X, Tachibana H, Tsutsumi Y (2000) Serologic response to Blastocystis hominis infection in asymptomatic individuals. Tokai J Exp Clin Med 25:51–56
28. Albrecht H, Stellbrink HJ, Koperski K, Greten H (1995) Blastocystis hominis in human immunodeficiency virus-related diarrhea. Scand J Gastroenterol 30:909–914
29. Sanchez-Aguillon F, Lopez-Escamilla E, Velez-Perez F, Martinez-Flores WA, Rodriguez-Zulueta P, Martinez-Ocaña J, Martinez-Hernandez F, Romero-Valdovinos M, Maravilla P (2013) Parasitic infections in a Mexican HIV/AIDS cohort. J Infect Dev Ctries 7:763–766. doi:10.3855/jidc.3512
30. Martín-Sánchez AM, Canut-Blasco A, Rodríguez-Hernández J, Montes-Martínez I, García-Rodríguez JA (1992) Epidemiology and clinical significance of Blastocystis hominis in different population groups in Salamanca (Spain). Eur J Epidemiol 8:553–559. doi:10.1007/BF00146376
31. El Safadi D, Gaayeb L, Meloni D, Cian A, Poirier P, Wawrzyniak I, Delbac F, Dabboussi F, Delhaes L, Seck M, Hamze M, Riveau G, Viscogliosi E (2014) Children of Senegal River Basin show the highest prevalence of Blastocystis sp. ever observed worldwide. BMC Infect Dis 14:164–174. doi:10.1186/1471-2334-14-164
32. Doyle PW, Helgason MM, Mathias RG, Proctor EM (1990) Epidemiology and pathogenicity of Blastocystis hominis. J Clin Microbiol 28:116–121
33. Lu CT, Sung YJ (2009) Epidemiology of Blastocystis hominis and other intestinal parasites among the immigrant population in northeastern Taiwan by routine physical examination for residence approval. J Microbiol Immunol Infect 42:505–509
34. Zaglool DAM, Khodari YAW, Farooq MU (2012) Blastocystis hominis and allergic skin diseases; a single centre experience. J Health Sci 2:66–69. doi:10.17532/jhsci.2012.66
35. Tan TC, Suresh KG (2006) Predominance of amoeboid forms of Blastocystis hominis in isolates from symptomatic patients. Parasitol Res 98:189–193. doi:10.1007/s00436-005-0033-7
36. Elghareeb AS, Younis MS, El Fakahany AF, Nagaty IM, Nagib MM (2015) Laboratory diagnosis of Blastocystis spp. in diarrheic patients. Trop Parasitol 5(1):36–41. doi:10.4103/2229-5070.149919
37. Abaza SMM (2000) Blastocystis hominis: update. Review article
38. Stenzel DJ, Boreham PF, McDougall R (1991) Ultrastructure of Blastocystis hominis in human stool samples. Int J Parasitol 21:807–812. doi:10.1016/0020-7519(91)90149-2
39. Yoshikawa H, Wu Z, Kimata I, Iseki M, Ali IK, Hossain MB, Zaman V, Haque R, Takahashi Y (2004) Polymerase chain reaction-based genotype classification among human Blastocystis hominis populations isolated from different countries. Parasitol Res 92:22–29. doi:10.1007/s00436-003-0995-2
40. Scicluna SM, Tawari B, Clark CG (2006) DNA barcoding of Blastocystis. Protist 157(1):77–85. doi:10.1016/j.protis.2005.12.001
41. Parkar U, Traub RJ, Vitali S, Elliot A, Levecke B, Robertson I, Geurden T, Steele J, Drake B, Thompson RC (2010) Molecular characterization of Blastocystis isolates from zoo animals and their animal-keepers. Vet Parasitol 169:8–17. doi:10.1016/j.vetpar.2009.12.032
42. Ramírez JD, Sánchez A, Hernández C, Flórez C, Bernal MC, Giraldo JC, Reyes P, López MC, García L, Cooper PJ, Vicuña Y, Mongi F, Casero RD (2016) Geographic distribution of human Blastocystis subtypes in South America. Infect Genet Evol 41:32–35. doi:10.1016/j.meegid.2016.03.017
43. Clark CG (1997) Extensive genetic diversity in Blastocystis hominis. Mol Biochem Parasitol 87:79–83. doi:10.1016/S0166-6851(97)00046-7
44. Poirier P, Wawrzyniak I, Vivarès CP, Delbac F, El Alaoui H (2012) New insights into Blastocystis spp.: a potential link with irritable bowel syndrome. PLoS Pathog 8, e1002545. doi:10.1371/journal.ppat.1002545
45. Puthia MK, Lu J, Tan KSW (2008) Blastocystis ratti contains cysteine proteases that mediate interleukin-8 response from human intestinal epithelial cells In an NF-kappaB-dependent manner. Eukaryot Cell 7:435–443. doi:10.1128/EC.00371-07
46. Yan Y, Su S, Lai R, Liao H, Ye J, Li X, Luo X, Chen G (2006) Genetic variability of Blastocystis hominis isolates in China. Parasitol Res 99:597–601. doi:10.1007/s00436-006-0186-z
47. El Safadi D, Meloni D, Poirier P, Osman M, Cian A, Gaayeb L, Wawrzyniak I, Delbac F, El Alaoui H, Delhaes L, Dei-Cas E, Mallat H, Dabboussi F, Hamze M, Viscogliosi E (2013) Molecular epidemiology of Blastocystis in Lebanon and correlation between subtype 1 and gastrointestinal symptoms. Am J Trop Med Hyg 88:1203–1206. doi:10.4269/ajtmh.12-0777
48. Stensvold CR, Christiansen DB, Olsen KE, Nielsen HV (2011) Blastocystis sp. subtype 4 is common in Danish Blastocystis-positive patients presenting with acute diarrhea. Am J Trop Med Hyg 84:883–885. doi:10.4269/ajtmh.2011.11-0005
49. Abdel-Hameed DM, Hassanin OM (2011) Proteaese activity of Blastocystis hominis subtype3 in symptomatic and asymptomatic patients. Parasitol Res 109:321–327. doi:10.1007/s00436-011-2259-x
50. Teow WL, Ho LC, Ng GC, Chan YC, Yap EH, Chan PP, Howe J, Zaman V, Singh M (1992) Virus-like particles in a Blastocystis species from the sea-snake, Lapemis hardwickii. Int J Parasitol 22:1029–1032. doi:10.1016/0020-7519(92)90065-S
51. Berrilli F, Di Cave D, Cavallero S, D’Amelio S (2012) Interactions between parasites and microbial communities in the human gut. Front Cell Infect Microbiol 2:141. doi:10.3389/fcimb.2012.00141
52. Mirza H, Tan KSW (2009) Blastocystis exhibits inter- and intra-subtype variation in cysteine protease activity. Parasitol Res 104:355–361. doi:10.1007/s00436-008-1203-1
53. Puthia MK, Vaithilingam A, Lu J, Tan KSW (2005) Degradation of human secretory immunoglobulin A by Blastocystis. Parasitol Res 97:386–389. doi:10.1007/s00436-005-1461-0
54. Nourrisson C, Wawrzyniak I, Cian A, Livrelli V, Viscogliosi E, Delbac F, Poirier P (2016) On Blastocystis secreted cysteine proteases: a legumain-activated cathepsin B increases paracellular permeability of intestinal Caco-2 cell monolayers. Parasitology 146(13):1713–1722. doi:10.1017/S0031182016001396
55. Wawrzyniak I, Texier C, Poirier P, Viscogliosi E, Tan KS, Delbac F, El Alaoui H (2012) Characterization of two cysteine proteases secreted by Blastocystis ST7, a human intestinal parasite. Parasitol Int 61:437–442. doi:10.1016/j.parint.2012.02.007
56. Hameed DM, Hassanin OM, Zuel-Fakkar NM (2011) Association of Blastocystis hominis genetic subtypes with urticaria. Parasitol Res 108:553–560. doi:10.1007/s00436-010-2097-2
57. Vogelberg C, Stensvold CR, Monecke S, Ditzen A, Stopsack K, Heinrich-Gräfe U, Pöhlmann C (2010) Blastocystis sp. subtype 2 detection during recurrence of gastrointestinal and urticarial symptoms. Parasitol Int 59:469–471. doi:10.1016/j.parint.2010.03.009
58. Zuel-Fakkar NM, Abdel Hameed DM, Hassanin OM (2011) Study of Blastocystis hominis isolates in urticaria: a case–control study. Clin Exp Dermatol 38:908–910. doi:10.1111/j.1365-2230.2011.04127.x
59. Verma R, Delfanian K (2013) Blastocystis hominis associated acute urticaria. Am J Med Sci 346:80–81. doi:10.1097/MAJ.0b013e3182801478
60. Katsarou-Katsari A, Vassalos CM, Tzanetou K, Spanakos G, Papadopoulou C, Vakalis N (2008) Acute urticaria associated with amoeboid forms of Blastocystis sp. subtype 3. Acta Derm Venereol 88:80–81. doi:10.2340/00015555-0338
61. Pasqui AL, Savini E, Saletti M, Guzzo C, Puccetti L, Auteri A (2004) Chronic urticaria and Blastocystis hominis infection: a case report. Eur Rev Med Pharmacol Sci 8:117–120
62. Vassalos CM, Spanakos G, Vassalou E, Papadopoulou C, Vakalis N (2010) Differences in clinical significance and morphologic features of Blastocystis sp subtype 3. Am J Clin Pathol 133:251–258. doi:10.1309/AJCPDOWQSL6E8DMN
63. Chandramathi S, Suresh K, Shuba S, Mahmood A, Kuppusamy UR (2010) High levels of oxidative stress in rats infected with Blastocystis hominis. Parasitology 137:605–611. doi:10.1017/S0031182009991351
64. Teo JD, MacAry PA, Tan KSW (2014) Pleiotropic effects of Blastocystis spp. subtypes 4 and 7 on ligand-specific toll-like receptor signaling and NF-κB activation in a human monocyte cell line. PLoS One 9, e89036. doi:10.1371/journal.pone.0089036
65. Balakrishnan DD, Kumar SG (2014) Higher Caspase-like activity in symptomatic isolates of Blastocystis spp. Parasit Vectors 7:219. doi:10.1186/1756-3305-7-219
66. Dave M, Higgins PD, Middha S, Rioux KP (2012) The human gut microbiome: current knowledge, challenges, and future directions. Transl Res 160(4):246–257. doi:10.1016/j.trsl.2012.05.003
67. Savage DC (1977) Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 31:107–133. doi:10.1146/annurev.mi.31.100177.000543
68. Rajilić-Stojanović M, de Vos WM (2014) The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev 38:996–1047. doi:10.1111/1574-6976.12075
69. Lagier JC, Armougom F, Million M, Hugon P, Pagnier I, Robert C, Bittar F, Fournous G, Gimenez G, Maraninchi M, Trape JF, Koonin EV, La Scola B, Raoult D (2012) Microbial culturomics: paradigm shift in the human gut microbiome study. Clin Microbiol Infect 18(12):1185–1193. doi:10.1111/1469-0691.12023
70. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI (2009) The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 1(6):6ra14. doi:10.1126/scitranslmed.3000322
71. Mueller S, Saunier K, Hanisch C, Norin E, Alm L, Midtvedt T, Cresci A, Silvi S, Orpianesi C, Verdenelli MC, Clavel T, Koebnick C, Zunft HJ, Doré J, Blaut M (2006) Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 72(2):1027–1033. doi:10.1128/AEM.72.2.1027-1033.2006
72. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA (2005) Diversity of the human intestinal microbial flora. Science 308(5728):1635–1638. doi:10.1126/science.1110591
73. Garmendia L, Hernandez A, Sanchez MB, Martinez JL (2012) Metagenomics and antibiotics. Clin Microbiol Infect 18(Suppl 4):27–31. doi:10.1111/j.1469-0691.2012.03868.x
74. Gueimonde M, Collado MC (2012) Metagenomics and probiotics. Clin Microbiol Infect 18(Suppl 4):32–34. doi:10.1111/j.1469-0691.2012.03873.x
75. O’Toole PW (2012) Changes in the intestinal microbiota from adulthood through to old age. Clin Microbiol Infect 18(Suppl 4):44–46. doi:10.1111/j.1469-0691.2012.03867.x
76. Pérez-Cobas AE, Artacho A, Knecht H, Ferrús ML, Friedrichs A, Ott SJ, Moya A, Latorre A, Gosalbes MJ (2013) Differential effects of antibiotic therapy on the structure and function of human gut microbiota. PLoS One 8(11), e80201. doi:10.1371/journal.pone.0080201
77. Qin J, Li R, Raes J et al (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464(7285):59–65. doi:10.1038/nature08821
78. Ukhanova M, Culpepper T, Baer D, Gordon D, Kanahori S, Valentine J, Neu J, Sun Y, Wang X, Mai V (2012) Gut microbiota correlates with energy gain from dietary fibre and appears to be associated with acute and chronic intestinal diseases. Clin Microbiol Infect 18(Suppl 4):62–66. doi:10.1111/j.1469-0691.2012.03859.x
79. Walker AW, Duncan SH, Harmsen HJ, Holtrop G, Welling GW, Flint HJ (2008) The species composition of the human intestinal microbiota differs between particle-associated and liquid phase communities. Environ Microbiol 10(2):3275–3283. doi:10.1111/j.1462-2920.2008.01717.x
80. Gillevet P, Sikaroodi M, Keshavarzian A, Mutlu EA (2010) Quantitative assessment of the human gut microbiome using multitag pyrosequencing. Chem Biodivers 7(5):1065–1075. doi:10.1002/cbdv.200900322
81. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444(7122):1027–1031. doi:10.1038/nature05414
82. Walter J, Ley R (2011) The human gut microbiome: ecology and recent evolutionary changes. Ann Rev Microbiol 65:411–429. doi:10.1146/annurev-micro-090110-102830
83. Sankar SA, Lagier JC, Pontarotti P, Raoult D, Fournier PE (2015) The human gut microbiome, a taxonomic conundrum. Syst Appl Microbiol 38(4):276–286. doi:10.1016/j.syapm.2015.03.004
84. Prakash S, Rodes L, Coussa-Charley M, Tomaro-Duchesneau C (2011) Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics 5:71–86. doi:10.2147/BTT.S19099
85. Clemente JC, Ursell LK, Parfrey LW, Knight R (2012) The impact of the gut microbiota on human health: an integrative view. Cell 148:1258–1270. doi:10.1016/j.cell.2012.01.035
86. Rohwer F (2003) Global phage diversity. Cell 113(2):141. doi:10.1016/S0092-8674(03)00276-9
87. Furlan M (2009) Viral and microbial dynamics in the human respiratory tract. Biology. San Diego State University
88. Haynes M, Rohwer F (2011) The human virome. In: Nelson KE (ed) Metagenomics of the human body. Springer, New York, pp 63–77
89. Letarov A, Kulikov E (2009) The bacteriophages in human- and animal body-associated microbial communities. J Appl Microbiol 107:1–13. doi:10.1111/j.1365-2672.2009.04143.x
90. Reyes A, Haynes M, Hanson N, Angly FE, Heath AC, Rohwer F, Gordon JI (2010) Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 466:334–338. doi:10.1038/nature09199
91. Kim MS, Park EJ, Roh SW, Bae JW (2011) Diversity and abundance of single-stranded DNA viruses in human feces. Appl Environ Microbiol 77:8062–8070. doi:10.1128/AEM.06331-11
92. Parfrey LW, Walters WA, Knight R (2011) Microbial eukaryotes in the human microbiome: ecology, evolution, and future directions. Front Microbiol 2:153. doi:10.3389/fmicb.2011.00153
93. Andersen LO, Vedel Nielsen H, Stensvold CR (2013) Waiting for the human intestinal eukaryotome. ISME J 7:1253–1255. doi:10.1038/ismej.2013.21
94. Bogitsh BJ, Carter CE, Oeltmann TN (2005) Human parasitology. Elsevier, Amsterdam
95. Barratt JL, Harkness J, Marriott D, Ellis JT, Stark D (2011) A review of Dientamoeba fragilis carriage in humans: Several reasons why this organism should be considered in the diagnosis of gastrointestinal illness. Gut Microbes 2:3–12. doi:10.4161/gmic.2.1.14755
96. Yavasoglu I, Kadikoylu G, Uysal H, Ertug S, Bolaman Z (2008) Is Blastocystis hominis a new etiologic factor or a coincidence in iron deficiency anemia? Eur J Haematol 8(1):47–50. doi:10.1111/j.1600-0609.2008.01080.x
97. El Deeb HK, Salah-Eldin H, Khodeer S (2012) Blastocystis hominis as a contributing risk factor for development of iron deficiency anemia in pregnant women. Parasitol Res 110(6):2167–2174. doi:10.1007/s00436-011-2743-3
98. El Deeb HK, Khodeer S (2013) Blastocystis spp.: frequency and subtype distribution in iron deficiency anemic versus non-anemic subjects from Egypt. J Parasitol 99(4):599–602. doi:10.1645/12-80.1
99. Scanlan PD, Stensvold CR (2013) Blastocystis: getting to grips with our guileful guest. Trends Parasitol 29(11):523–529. doi:10.1016/j.pt.2013.08.006
100. Kurt Ö, Doğruman Al F, Tanyüksel M (2016) Eradication of Blastocystis in humans: Really necessary for all? Parasitol Int 65:797–801. doi:10.1016/j.parint.2016.01.010
101. Leung JM, Davenport M, Wolff MJ, Wiens KE, Abidi WM, Poles MA, Cho I, Ullman T, Mayer L, Loke P (2014) IL-22-producing C4+ cells are depleted in actively inflamed colitis tissue. Mucosal Immunol 7:124–133. doi:10.1038/mi.2013.31
102. Giacometti A, Cirioni O, Fiorentini A, Fortuna M, Scalise G (1999) Irritable bowel syndrome in patients with Blastocystis hominis infection. Eur J Clin Microbiol Infect Dis 18:436–439
103. Yakoob J, Jafri W, Jafri N, Khan R, Islam M, Beg MA, Zaman V (2004) Irritable bowel syndrome: in search of an etiology: role of Blastocystis hominis. Am J Trop Med Hyg 70:383–385
104. Yakoob J, Jafri W, Beg MA, Abbas Z, Naz S, Islam M, Khan R (2010) Blastocystis hominis and Dientamoeba fragilis in patients fulfilling irritable bowel syndrome criteria. Parasitol Res 107:679–684. doi:10.1007/s00436-010-1918-7
105. Dogruman-Al F, Kustimur S, Yoshikawa H, Tuncer C, Simsek Z, Tanyuksel M, Araz E, Boorom K (2009) Blastocystis subtypes in irritable bowel syndrome and inflammatory bowel disease in Ankara, Turkey. Mem Inst Oswaldo Cruz 104:724–727. doi:10.1590/S0074-02762009000500011
106. Jimenez-Gonzalez DE, Martinez-Flores WA, Reyes-Gordillo J, Ramirez-Miranda ME, Arroyo-Escalante S, Romero-Valdovinos M, Stark D, Souza-Saldivar V, Martinez-Hernandez F, Flisser A, Olivo-Diaz A, Maravilla P (2012) Blastocystis infection is associated with irritable bowel syndrome in a Mexican patient population. Parasitol Res 110:1269–1275. doi:10.1007/s00436-011-2626-7
107. Nourrisson C, Scanzi J, Pereira B, NkoudMongo C, Wawrzyniak I, Cian A, Viscogliosi E, Livrelli V, Delbac F, Dapoigny M, Poirier P (2014) Blastocystis is associated with decrease of fecal microbiota protective bacteria: comparative analysis between patients with irritable bowel syndrome and control subjects. PLoS One 9(11), e111868. doi:10.1371/journal.pone.0111868
108. Nagel R, Traub RJ, Allcock RJN, Kwan MMS, Bielefeldt-Ohmann H (2016) Comparison of faecal microbiota in Blastocystis-positive and Blastocystis-negative irritable bowel syndrome patients. Microbiome 4(1):47. doi:10.1186/s40168-016-0191-0
109. Audebert C, Even G, Cian A, Blastocystis Investigation Group, Loywick A, Merlin S, Viscogliosi E, Chabé M (2016) Colonization with the enteric protozoa Blastocystis is associated with increased diversity of human gut bacterial microbiota. Sci Rep 6, 25255. doi:10.1038/srep25255
110. Tan KS, Singh M, Yap EH (2002) Recent advances in Blastocystis hominis research: hot spots in terra incognita. Int J Parasitol 32:789–804. doi:10.1016/S0020-7519(02)00005-X
111. Dinleyici EC, Eren M, Dogan N, Reyhanioglu S, Yargic ZA, Vandenplas Y (2011) Clinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystis hominis infection. Parasitol Res 108:541–545. doi:10.1007/s00436-010-2095-4
112. Lucía JF, Aguilar C, Betran A (2007) Blastocystis hominis colitis in a haemophilic patient as a cause of lower gastrointestinal bleeding. Haemophilia 13(2):224–225. doi:10.1111/j.1365-2516.2006.01434.x
113. Moghaddam DD, Ghadirian E, Azami M (2005) Blastocystis hominis and the evaluation of efficacy of metronidazole and trimethoprim/sulfamethoxazole. Parasitol Res 96(4):273–275. doi:10.1007/s00436-005-1363-1
114. Johnson PJ (1993) Metronidazole and drug resistance. Parasitol Today 9:183–186. doi:10.1016/0169-4758(93)90143-4
115. Voolmann T, Boreham PFL (1993) Metronidazole resistant Trichomonas vaginalis in Brisbane. Med J Aust 159:490
116. Girish S, Kumar S, Aminudin N (2015) Tongkat Ali (Eurycoma longifolia): a possible therapeutic candidate against Blastocystis sp. Parasit Vectors 8:332. doi:10.1186/s13071-015-0942-y
117. Mirza H, Wu Z, Kidwai F, Tan KSW (2011) A metronidazole-resistant isolate of Blastocystis spp. is susceptible to nitric oxide and downregulates intestinal epithelial inducible nitric oxide synthase by a novel parasite survival mechanism. Infect Immun 79(12):5019–5026. doi:10.1128/IAI.05632-11
118. Lemée V, Zaharia I, Nevez G, Rabodonirina M, Brasseur P, Ballet JJ, Favennec L (2000) Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France. J Antimicrob Chemother 46:819–821. doi:10.1093/jac/46.5.819
119. Haresh K, Suresh K, Khairul Anus A, Saminathan S (1999) Isolate resistance of Blastocystis hominis to metronidazole. Trop Med Int Health 4:274–277. doi:10.1046/j.1365-3156.1999.00398.x
120. Zaman V, Zaki M (1996) Resistance of Blastocystis hominis cysts to metronidazole. Trop Med Int Health 1:677–678. doi:10.1111/j.1365-3156.1996.tb00094.x
121. Stensvold CR, Smith HV, Nagel R, Olsen KEP, Traub RJ (2010) Eradication of Blastocystis carriage with antimicrobials: reality or delusion? J Clin Gastroenterol 44(2):85–90. doi:10.1097/MCG.0b013e3181bb86ba
122. Sekar U, Shanthi M (2013) Blastocystis: consensus of treatment and controversies. Trop Parasitol 3:35–39. doi:10.4103/2229-5070.113901
123. Roe FJ (1983) Toxicologic evaluation of metronidazole with particular reference to carcinogenic, mutagenic, and teratogenic potential. Surgery 93:158–164
124. Rokaya MB, Uprety Y, Poudel RC, Timsina B, Münzbergová Z, Asselin H, Tiwari A, Shrestha SS, Sigdel SR (2014) Traditional uses of medicinal plants in gastrointestinal disorders in Nepal. J Ethnopharmacol 158:221–229. doi:10.1016/j.jep.2014.10.014
125. Iimuro M, Shibata H, Kawamori T, Matsumoto T, Arakawa T, Sugimura T, Wakabayashi K (2002) Suppressive effects of garlic extract on Helicobacter pylori-induced gastritis in Mongolian gerbils. Cancer Lett 187:61–68. doi:10.1016/S0304-3835(02)00401-9
126. Goncagul G, Ayaz E (2010) Antimicrobial effect of garlic (Allium sativum) and traditional medicine. J Anim Vet Adv 9:1–4. doi:10.3923/javaa.2010.1.4
127. Majewski M (2014) Allium sativum: facts and myths regarding human health. Rocz Panstw Zakl Hig 65(1):1–8
128. Feldberg RS, Chang SC, Kotik AN, Nadler M, Neuwirth Z, Sundstrom DC, Thompson NH (1988) In vitro mechanism of inhibition of bacterial cell growth by allicin. Antimicrob Agents Chemother 32:1763–1768
129. Lin RJ, Chen CY, Chung LY, Yen CM (2010) Larvicidal activities of ginger (Zingiber officinale) against Angiostrongylus cantonensis. Acta Trop 115:69–76. doi:10.1016/j.actatropica.2009.12.007
130. Yakoob J, Abbas Z, Beg MA, Naz S, Awan S, Hamid S, Jafri W (2011) In vitro sensitivity of Blastocystis hominis to garlic, ginger, white cumin, and black pepper used in diet. Parasitol Res 109:379–385. doi:10.1007/s00436-011-2265-z
131. Abdel-Hafeez EH, Ahmad AK, Kamal AM, Abdellatif MZM, Abdelgelil NH (2015) In vivo antiprotozoan effects of garlic (Allium sativum) and ginger (Zingiber officinale) extracts on experimentally infected mice with Blastocystis spp. Parasitol Res 114(9):3439–3444. doi:10.1007/s00436-015-4569-x
132. Abdel-Hafeez EH, Ahmad AK, Andelgelil NH, Abdellatif MZM, Kamal AM, Mohamed RM (2015) In vitro effect of some Egyptian herbal extracts against Blastocystis hominis. J Egypt Soc Parasitol 45(1):93–100. doi:10.12816/0010854
133. Banerjee SK, Mukherjee PK, Maulik SK (2003) Garlic as an antioxidant: the good, the bad and the ugly. Phytother Res 17:97–106. doi:10.1002/ptr.1281
134. Ahmed RS, Seth V, Banerjee BD (2000) Influence of dietary ginger (Zingiber officinales Rosc) on antioxidant defense system in rat: comparison with ascorbic acid. Indian J Exp Biol 38:604–606
135. Dugasani S, Pichika MR, Nadarajah VD, Balijepalli MK, Tandra S, Korlakunta JN (2010) Comparative antioxidant and anti-inflammatory effects of [6]-gingerol, [8]-gingerol, [10]-gingerol and [6]-shogaol. J Ethnopharmacol 127:515–520. doi:10.1016/j.jep.2009.10.004
136. Potoka DA, Nadler EP, Upperman JS, Ford HR (2002) Role of nitric oxide and peroxynitrite in gut barrier failure. World J Surg 26:806–811. doi:10.1007/s00268-002-4056-2
137. Lanas A (2008) Role of nitric oxide in the gastrointestinal tract. Arthritis Res Ther 10(Suppl 2):S4. doi:10.1186/ar2465
138. El Deeb HK, Al Khadrawy FM, Abd El-Hameid AK (2012) Inhibitory effect of Ferula asafoetida L. (Umbelliferae) on Blastocystis sp. subtype 3 growth in vitro. Parasitol Res 111:1213–1221. doi:10.1007/s00436-012-2955-1
139. Abd El-Razek MH (2007) A new ester isolated from Ferula assa-foetida L. Biosci Biotechnol Biochem 71(9):2300–2303. doi:10.1271/bbb.70065
140. Kuo PC, Shi LS, Damu AG, Su CR, Huang CH, Ke CH, Wu JB, Lin AJ, Bastow KF, Lee KH, Wu TS (2003) Cytotoxic and antimalarial beta-carboline alkaloids from the roots of Eurycoma longifolia. J Nat Prod 66(10):1324–1327. doi:10.1021/np030277n
141. Gutiérrez RMP (2007) Handbook of compounds with antiprotozoal activity isolated from plants. Nova, New York
142. Vital PG, Rivera WL (2009) Antimicrobial activity and cytotoxicity of Chromolaena odorata (L. f.) King and Robinson and Uncaria perrottetii (A. Rich) Merr. Extracts. J Med Plants Res 3(7):511–518
143. Özbílgín A, Durmuşkahya C, Kílímcíoğlu AA, Kayalar H, Kurt Ö, Ermíş VÖ, Tabak T, Östan Í (2013) In vitro efficacy of Quercus infectoria Oliv. and Achillea millefolium L. extracts against Blastocystis spp. isolates. Kafkas Univ Vet Fak Derg 19(3):511–516. doi:10.9775/kvfd.2012.8196
144. El Wakil SS (2007) Evaluation of the in vitro effect of Nigella sativa aqueous extract on Blastocystis hominis isolates. J Egypt Soc Parasitol 37:801–813
145. Brewmer Christensen C, Soelberg J, Stensvold CR, Jäger AK (2015) Activity of medicinal plants from Ghana against the parasitic gut protist Blastocystis. J Ethnopharmacol 174:569–575. doi:10.1016/j.jep.2015.03.006
146. Sawangjaroen N, Sawangjaroen K (2005) The effects of extracts from anti-diarrheic Thai medicinal plants on the in vitro growth of the intestinal protozoa parasite: Blastocystis hominis. J Ethnopharmacol 98:67–72. doi:10.1016/j.jep.2004.12.024
147. Force M, Sparks WS, Ronzio RA (2000) Inhibition of enteric parasites by emulsified oil of oregano in vivo. Phytother Res 14:213–214
148. Vandenplas Y, Huys G, Daube G (2015) Probiotics: an update. J Pediatr (Rio J) 91(1):6–21. doi:10.1016/j.jped.2014.08.005